Sparks Susan E, Escolar Diana M
Clinical Genetics, Department of Pediatrics, Levine Children's Hospital at Carolinas Medical Center, Charlotte, NC 28232-2861, USA.
Handb Clin Neurol. 2011;101:47-79. doi: 10.1016/B978-0-08-045031-5.00004-9.
Congenital muscular dystrophies (CMDs) are a heterogeneous group of disorders characterized by muscle weakness from birth, or shortly after, and variable clinical manifestations of the eye and central nervous system. Some of these disorders are fatal in the first years of life, whereas others have a milder course, with survival into adulthood. The CMDs were initially classified by clinical features and country of origin; however, with new molecular techniques it is now possible to classify these patients better. More than 10 genes have been identified to date that cause forms of CMD. However, even with current molecular diagnostic techniques, only approximately 25-50% of patients with CMD have an identifiable genetic mutation. In addition, some phenotypic classifications have been attempted. There is significant overlap between the phenotypic and molecular classifications, making diagnosis within this heterogeneous group of disorders difficult.
先天性肌营养不良症(CMD)是一组异质性疾病,其特征为出生时或出生后不久即出现肌肉无力,以及眼睛和中枢神经系统的临床表现各异。其中一些疾病在生命的最初几年是致命的,而另一些则病程较轻,可存活至成年。CMD最初是根据临床特征和起源国进行分类的;然而,随着新的分子技术的出现,现在可以更好地对这些患者进行分类。迄今为止,已鉴定出10多个导致CMD形式的基因。然而,即使使用当前的分子诊断技术,也只有大约25%-50%的CMD患者有可识别的基因突变。此外,还尝试了一些表型分类。表型分类和分子分类之间存在显著重叠,使得在这组异质性疾病中进行诊断变得困难。